Gregg Sando | Founder and Chief Executive Officer
Cell Medica Ltd

Gregg Sando, Founder and Chief Executive Officer, Cell Medica Ltd

After a career in investment banking based in New York and then London, Gregg enrolled in the post-graduate immunology programme at the Imperial College School of Medicine, London.   His research work focused on the use of an agonist PD-1 antibody to inhibit autoimmune T cell responses.    Recognizing the potential of harnessing the immune system to treat human diseases, Gregg launched Cell Medica in 2006 with leading research scientists in the UK and US who were pioneering the use of cellular immunotherapy for the treatment of cancer and infections.   Gregg holds degrees from Imperial College (MSc Immunology), University of Chicago (MBA) and Harvard University (BA Biochemistry).

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 14:30

Making cellular immunotherapy for the treatment of cancer work at scale as a business

Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 17:05

Panel: A new landscape for investment and innovation in the UK

How do Innovate UK and its family of networks and innovation centres support innovative advanced therapy businesses?
How does government investment support the development of new partnerships and supply chains?
How will the UK’s Industrial Strategy drive growth in the sector?

back to speakers

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com